Shares of Diploma PLC (LON:DPLM – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the eight analysts that are presently covering the firm, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is GBX 7,400.
Several equities analysts recently weighed in on DPLM shares. Berenberg Bank restated a “buy” rating and set a GBX 9,000 target price on shares of Diploma in a report on Monday, July 20th. JPMorgan Chase & Co. upped their price target on Diploma from GBX 5,760 to GBX 8,250 and gave the company an “overweight” rating in a research note on Monday, August 24th. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating and set a GBX 7,400 price target on shares of Diploma in a report on Tuesday, September 8th.
Get Our Latest Stock Analysis on DPLM
Insiders Place Their Bets
In other Diploma news, insider Katie Bickerstaffe bought 246 shares of the firm’s stock in a transaction dated Wednesday, September 23rd. The stock was acquired at an average cost of GBX 7,696 per share, for a total transaction of £18,932.16. Insiders own 1.14% of the company’s stock.
Diploma Stock Up 0.9%
Shares of LON DPLM opened at GBX 6,990 on Friday. The firm has a market capitalization of £9.37 billion, a price-to-earnings ratio of 49.64, a PEG ratio of 2.82 and a beta of 0.92. Diploma has a 52-week low of GBX 4,970 and a 52-week high of GBX 7,980. The company has a debt-to-equity ratio of 47.65, a quick ratio of 0.80 and a current ratio of 2.06. The stock has a 50 day moving average price of GBX 7,425.45 and a 200 day moving average price of GBX 6,758.19.
Diploma Company Profile
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Further Reading
- Five stocks we like better than Diploma
- MarketBeat Week in Review – 11/2 – 11/6
- Q3 Earnings Have Investors Wondering: Is Mercado Libre Finally a Buy?
- CVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop?
- Array and Shoals Are Merging: Who Really Wins the All-Stock Solar Deal?
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.
